Bailong Chuangyuan(SH:605016) Xin Lang Cai Jing·2025-08-04 08:10Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing growth driven by its health sweetener products, particularly allulose, and benefits from its stake in a rural commercial bank amid the depreciation of the RMB [2][3][4]. Group 1: Company Overview - The company specializes in the research, production, and sales of prebiotics, dietary fibers, and health sweeteners, with a revenue composition of 54.15% from dietary fibers, 28.00% from prebiotics, 13.57% from health sweeteners, and 3.91% from other products [8]. - As of July 20, the number of shareholders is 11,800, a decrease of 5.12%, with an average of 35,642 circulating shares per person, an increase of 5.40% [8]. - The company was established on December 30, 2005, and went public on April 21, 2021 [8]. Group 2: Financial Performance - In the first quarter of 2025, the company achieved a revenue of 313 million yuan, representing a year-on-year growth of 24.27%, and a net profit attributable to shareholders of 81.42 million yuan, up 52.06% year-on-year [8]. - Cumulative cash dividends since the company's A-share listing amount to 162 million yuan, with 151 million yuan distributed over the past three years [9]. Group 3: Market Position and Recognition - The company holds a 5.14% stake in Shandong Yucheng Rural Commercial Bank, which is expected to benefit from the depreciation of the RMB [3][4]. - It has been recognized as a "specialized, refined, characteristic, and innovative" small giant enterprise, indicating its strong market position and innovation capabilities [4]. Group 4: Stock Performance - On August 4, the stock price increased by 2.85%, with a trading volume of 130 million yuan and a turnover rate of 1.54%, bringing the total market capitalization to 8.493 billion yuan [1]. - The average trading cost of the stock is 19.84 yuan, with the current price near a support level of 19.68 yuan [7]. Group 5: Institutional Holdings - As of March 31, 2025, notable institutional shareholders include Penghua New Emerging Industries Mixed Fund and Guotai Jiangyuan Advantage Selection Flexible Allocation Mixed Fund, with some new entries among the top ten shareholders [10].